| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 2.59e-15 | 114 | 112 | 14 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.61e-15 | 124 | 112 | 14 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 3.53e-14 | 137 | 112 | 14 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 3.78e-12 | 192 | 112 | 14 | GO:0008234 |
| GeneOntologyMolecularFunction | alpha-amylase activity | 5.07e-12 | 5 | 112 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 3.03e-11 | 6 | 112 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 2.11e-08 | 16 | 112 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | peptidase activity | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.77e-05 | 654 | 112 | 14 | GO:0008233 |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 2.87e-04 | 103 | 112 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity | 6.43e-04 | 7 | 112 | 2 | GO:0046934 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase inhibitor activity | 1.09e-03 | 9 | 112 | 2 | GO:0019828 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 1.32e-03 | 144 | 112 | 5 | GO:0016798 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 6.23e-15 | 125 | 112 | 14 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 4.60e-14 | 144 | 112 | 14 | GO:0070646 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | TRAF3IP2 USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 BIRC2 USP17L10 USP17L19 TRIP12 BIRC6 USP17L18 USP17L17 ASB8 SOCS5 RNF10 USP17L3 RPGR IFT80 USP17L22 USP17L15 | 4.06e-09 | 1009 | 112 | 23 | GO:0070647 |
| GeneOntologyBiologicalProcess | post-translational protein modification | TRAF3IP2 USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 BIRC2 USP17L10 USP17L19 TRIP12 BIRC6 USP17L18 USP17L17 ASB8 SOCS5 RNF10 USP17L3 RPGR IFT80 USP17L22 USP17L15 | 1.31e-08 | 1074 | 112 | 23 | GO:0043687 |
| GeneOntologyBiologicalProcess | growth hormone receptor signaling pathway via JAK-STAT | 1.82e-05 | 10 | 112 | 3 | GO:0060397 | |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 7.41e-05 | 129 | 112 | 6 | GO:0043406 | |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 8.74e-05 | 3 | 112 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 8.91e-05 | 193 | 112 | 7 | GO:0071902 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | CLN8 USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 SYNE1 USP17L5 USP17L10 USP17L19 USP17L18 GRAMD1B LPIN3 PTPN1 ANKRD13C USP17L17 USP17L3 LRBA USP17L22 USP17L15 SORL1 | 6.71e-06 | 1327 | 112 | 21 | GO:0042175 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | CLN8 USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 GRAMD1B LPIN3 PTPN1 ANKRD13C USP17L17 USP17L3 LRBA USP17L22 USP17L15 SORL1 | 1.61e-05 | 1293 | 112 | 20 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | CLN8 USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 GRAMD1B LPIN3 PTPN1 ANKRD13C USP17L17 USP17L3 LRBA USP17L22 USP17L15 SORL1 | 1.72e-05 | 1299 | 112 | 20 | GO:0098827 |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class IB | 1.70e-04 | 4 | 112 | 2 | GO:0005944 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex | 4.94e-04 | 29 | 112 | 3 | GO:0005942 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class I | 9.99e-04 | 9 | 112 | 2 | GO:0097651 | |
| GeneOntologyCellularComponent | phosphatidylinositol 3-kinase complex, class IA | 9.99e-04 | 9 | 112 | 2 | GO:0005943 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 1.13e-03 | 85 | 112 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | main axon | 1.34e-03 | 89 | 112 | 4 | GO:0044304 | |
| Domain | HABP4_PAI-RBP1 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 | 6.79e-22 | 16 | 109 | 11 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 | 6.79e-22 | 16 | 109 | 11 | IPR006861 |
| Domain | USP_CS | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 | 6.89e-17 | 66 | 109 | 13 | IPR018200 |
| Domain | UCH | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 | 1.91e-16 | 71 | 109 | 13 | PF00443 |
| Domain | USP_2 | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 | 1.91e-16 | 71 | 109 | 13 | PS00973 |
| Domain | USP_3 | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 | 2.32e-16 | 72 | 109 | 13 | PS50235 |
| Domain | USP_dom | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 | 2.32e-16 | 72 | 109 | 13 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 | 2.32e-16 | 72 | 109 | 13 | IPR001394 |
| Domain | USP_1 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 | 6.73e-15 | 70 | 109 | 12 | PS00972 |
| Domain | Aamy_C | 1.10e-09 | 4 | 109 | 4 | SM00632 | |
| Domain | Alpha_amylase | 1.10e-09 | 4 | 109 | 4 | IPR006046 | |
| Domain | Alpha-amylase_C | 5.46e-09 | 5 | 109 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 5.46e-09 | 5 | 109 | 4 | IPR006048 | |
| Domain | Aamy | 3.79e-08 | 7 | 109 | 4 | SM00642 | |
| Domain | Glyco_hydro_13_cat_dom | 3.79e-08 | 7 | 109 | 4 | IPR006047 | |
| Domain | Alpha-amylase | 3.79e-08 | 7 | 109 | 4 | PF00128 | |
| Domain | A-amylase_C | 1.93e-07 | 3 | 109 | 3 | IPR031319 | |
| Domain | Glyco_hydro_b | 1.43e-06 | 15 | 109 | 4 | IPR013780 | |
| Domain | Glyco_hydro_13 | 3.82e-06 | 6 | 109 | 3 | IPR015902 | |
| Domain | - | 6.72e-05 | 14 | 109 | 3 | 2.60.40.1180 | |
| Domain | Glyco_hydro_catalytic_dom | 6.95e-05 | 38 | 109 | 4 | IPR013781 | |
| Domain | Glycoside_hydrolase_SF | 2.58e-04 | 53 | 109 | 4 | IPR017853 | |
| Domain | STAT_TF_prot_interaction | 6.95e-04 | 7 | 109 | 2 | IPR013799 | |
| Domain | STAT_TF_DNA-bd_sub | 6.95e-04 | 7 | 109 | 2 | IPR012345 | |
| Domain | STAT | 6.95e-04 | 7 | 109 | 2 | IPR001217 | |
| Domain | STAT_TF_coiled-coil | 6.95e-04 | 7 | 109 | 2 | IPR015988 | |
| Domain | - | 6.95e-04 | 7 | 109 | 2 | 2.60.40.630 | |
| Domain | STAT_int | 6.95e-04 | 7 | 109 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 6.95e-04 | 7 | 109 | 2 | IPR013801 | |
| Domain | STAT_bind | 6.95e-04 | 7 | 109 | 2 | PF02864 | |
| Domain | STAT_int | 6.95e-04 | 7 | 109 | 2 | PF02865 | |
| Domain | - | 6.95e-04 | 7 | 109 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 6.95e-04 | 7 | 109 | 2 | PF01017 | |
| Domain | - | 6.95e-04 | 7 | 109 | 2 | 1.20.1050.20 | |
| Domain | BIR | 9.24e-04 | 8 | 109 | 2 | SM00238 | |
| Domain | - | 9.24e-04 | 8 | 109 | 2 | 1.10.1170.10 | |
| Domain | STAT_TF_alpha | 9.24e-04 | 8 | 109 | 2 | IPR013800 | |
| Domain | BIR | 9.24e-04 | 8 | 109 | 2 | PF00653 | |
| Domain | BIR_REPEAT_2 | 9.24e-04 | 8 | 109 | 2 | PS50143 | |
| Domain | Carboxylesterase_B_AS | 9.24e-04 | 8 | 109 | 2 | IPR019826 | |
| Domain | CARBOXYLESTERASE_B_1 | 9.24e-04 | 8 | 109 | 2 | PS00122 | |
| Domain | BIR_rpt | 9.24e-04 | 8 | 109 | 2 | IPR001370 | |
| Domain | BIR_REPEAT_1 | 9.24e-04 | 8 | 109 | 2 | PS01282 | |
| Domain | - | 1.10e-03 | 35 | 109 | 3 | 3.20.20.80 | |
| Domain | LisH | 1.18e-03 | 9 | 109 | 2 | PF08513 | |
| Domain | COS_domain | 2.14e-03 | 12 | 109 | 2 | IPR017903 | |
| Domain | COS | 2.14e-03 | 12 | 109 | 2 | PS51262 | |
| Domain | Carboxylesterase_B_CS | 2.52e-03 | 13 | 109 | 2 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 2.93e-03 | 14 | 109 | 2 | PS00941 | |
| Domain | Ldl_recept_b | 2.93e-03 | 14 | 109 | 2 | PF00058 | |
| Domain | LDLRB | 2.93e-03 | 14 | 109 | 2 | PS51120 | |
| Domain | COesterase | 2.93e-03 | 14 | 109 | 2 | PF00135 | |
| Domain | CarbesteraseB | 2.93e-03 | 14 | 109 | 2 | IPR002018 | |
| Domain | LY | 3.37e-03 | 15 | 109 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.37e-03 | 15 | 109 | 2 | IPR000033 | |
| Domain | - | 3.39e-03 | 333 | 109 | 7 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.51e-03 | 335 | 109 | 7 | IPR015943 | |
| Domain | WD40 | 4.14e-03 | 259 | 109 | 6 | PF00400 | |
| Domain | WD40 | 4.88e-03 | 268 | 109 | 6 | SM00320 | |
| Domain | WD40_repeat | 5.24e-03 | 272 | 109 | 6 | IPR001680 | |
| Domain | WD_REPEATS_1 | 5.81e-03 | 278 | 109 | 6 | PS00678 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 6.30e-19 | 45 | 89 | 13 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 BIRC2 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 7.23e-12 | 221 | 89 | 15 | M27578 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 BIRC2 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.37e-11 | 191 | 89 | 14 | MM15289 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 BIRC2 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 5.19e-10 | 299 | 89 | 15 | M27574 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 BIRC2 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 9.14e-10 | 262 | 89 | 14 | MM15286 |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 1.11e-09 | 9 | 89 | 5 | M47622 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 EGF USP17L17 PRKACB USP17L3 USP17L22 USP17L15 | 1.21e-09 | 318 | 89 | 15 | MM15278 |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 4.01e-09 | 11 | 89 | 5 | M1091 | |
| Pathway | REACTOME_DIGESTION | 4.94e-09 | 23 | 89 | 6 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 1.80e-08 | 28 | 89 | 6 | M27837 | |
| Pathway | REACTOME_DIGESTION | 8.18e-06 | 21 | 89 | 4 | MM15526 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 8.36e-06 | 7 | 89 | 3 | M47430 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.33e-05 | 8 | 89 | 3 | MM14717 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 1.70e-05 | 25 | 89 | 4 | MM15557 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.84e-05 | 52 | 89 | 5 | M14171 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 1.28e-04 | 16 | 89 | 3 | MM15710 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.28e-04 | 16 | 89 | 3 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.28e-04 | 16 | 89 | 3 | MM1420 | |
| Pathway | PID_TCPTP_PATHWAY | 1.38e-04 | 42 | 89 | 4 | M91 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 2.20e-04 | 87 | 89 | 5 | M12467 | |
| Pathway | WP_AMINO_ACID_METABOLISM | 2.72e-04 | 91 | 89 | 5 | M39570 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 3.19e-04 | 52 | 89 | 4 | M2404 | |
| Pathway | PID_PTP1B_PATHWAY | 3.19e-04 | 52 | 89 | 4 | M50 | |
| Pathway | WP_AMINO_ACID_METABOLISM | 3.83e-04 | 98 | 89 | 5 | MM15942 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 3.89e-04 | 5 | 89 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 3.89e-04 | 5 | 89 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 3.89e-04 | 5 | 89 | 2 | M49006 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 3.93e-04 | 23 | 89 | 3 | MM1424 | |
| Pathway | BIOCARTA_GLEEVEC_PATHWAY | 3.93e-04 | 23 | 89 | 3 | M7897 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 4.47e-04 | 24 | 89 | 3 | M11520 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 4.47e-04 | 24 | 89 | 3 | M519 | |
| Pathway | BIOCARTA_TPO_PATHWAY | 5.06e-04 | 25 | 89 | 3 | MM1519 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 5.06e-04 | 25 | 89 | 3 | M27865 | |
| Pathway | WP_IL7_SIGNALING | 5.06e-04 | 25 | 89 | 3 | M39499 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 5.69e-04 | 26 | 89 | 3 | M39687 | |
| Pathway | PID_IL3_PATHWAY | 5.69e-04 | 26 | 89 | 3 | M182 | |
| Pathway | WP_EPO_RECEPTOR_SIGNALING | 5.69e-04 | 26 | 89 | 3 | MM15896 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 5.82e-04 | 6 | 89 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 5.82e-04 | 6 | 89 | 2 | MM15621 | |
| Pathway | BIOCARTA_GH_PATHWAY | 6.38e-04 | 27 | 89 | 3 | M9043 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 8.11e-04 | 7 | 89 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 8.11e-04 | 7 | 89 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 8.11e-04 | 7 | 89 | 2 | M47646 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 8.11e-04 | 7 | 89 | 2 | M27907 | |
| Pathway | WP_IL5_SIGNALING_PATHWAY | 8.88e-04 | 68 | 89 | 4 | MM15930 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 1.04e-03 | 71 | 89 | 4 | MM15947 | |
| Pathway | WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER | 1.06e-03 | 32 | 89 | 3 | M39445 | |
| Pathway | BIOCARTA_KREB_PATHWAY | 1.08e-03 | 8 | 89 | 2 | M6831 | |
| Pathway | WP_BDNFTRKB_SIGNALING | 1.16e-03 | 33 | 89 | 3 | M39532 | |
| Pathway | BIOCARTA_GH_PATHWAY | 1.16e-03 | 33 | 89 | 3 | MM1404 | |
| Pathway | KEGG_CHRONIC_MYELOID_LEUKEMIA | 1.16e-03 | 73 | 89 | 4 | M321 | |
| Pathway | PID_PDGFRB_PATHWAY | 1.33e-03 | 129 | 89 | 5 | M186 | |
| Pathway | WP_PROLACTIN_SIGNALING | 1.35e-03 | 76 | 89 | 4 | M39601 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 1.38e-03 | 9 | 89 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.38e-03 | 9 | 89 | 2 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 1.38e-03 | 9 | 89 | 2 | M8066 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 1.49e-03 | 36 | 89 | 3 | MM1418 | |
| Pathway | PID_GMCSF_PATHWAY | 1.49e-03 | 36 | 89 | 3 | M22 | |
| Pathway | BIOCARTA_IL2RB_PATHWAY | 1.62e-03 | 37 | 89 | 3 | M8615 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.72e-03 | 10 | 89 | 2 | M27898 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 1.72e-03 | 10 | 89 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 1.72e-03 | 10 | 89 | 2 | MM15618 | |
| Pathway | REACTOME_FLT3_SIGNALING | 1.75e-03 | 38 | 89 | 3 | M29803 | |
| Pathway | WP_IL5_SIGNALING | 2.03e-03 | 40 | 89 | 3 | M39392 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 2.09e-03 | 11 | 89 | 2 | M27195 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 2.09e-03 | 11 | 89 | 2 | MM15578 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 4.38e-28 | 21 | 113 | 13 | 8622927 |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 4.38e-28 | 21 | 113 | 13 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 4.38e-28 | 21 | 113 | 13 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 4.38e-28 | 21 | 113 | 13 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 4.38e-28 | 21 | 113 | 13 | 12447969 |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 4.38e-28 | 21 | 113 | 13 | 18980247 | |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.07e-27 | 22 | 113 | 13 | 9154835 | |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 4.93e-27 | 33 | 113 | 14 | 20228807 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 5.33e-27 | 24 | 113 | 13 | 8995226 |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.35e-27 | 34 | 113 | 14 | 20403174 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.35e-27 | 34 | 113 | 14 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.35e-27 | 34 | 113 | 14 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.35e-27 | 34 | 113 | 14 | 19188362 |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.35e-27 | 34 | 113 | 14 | 11941478 | |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.35e-27 | 34 | 113 | 14 | 17109758 | |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.35e-27 | 34 | 113 | 14 | 20388806 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.35e-27 | 34 | 113 | 14 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.35e-27 | 34 | 113 | 14 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.35e-27 | 34 | 113 | 14 | 20368735 |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.35e-27 | 34 | 113 | 14 | 10936051 | |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.35e-27 | 34 | 113 | 14 | 21448158 | |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.11e-26 | 25 | 113 | 13 | 21115691 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.39e-26 | 35 | 113 | 14 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.39e-26 | 35 | 113 | 14 | 21239494 |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 2.21e-26 | 26 | 113 | 13 | 35816173 | |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 2.27e-26 | 36 | 113 | 14 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 3.63e-26 | 37 | 113 | 14 | 20228808 |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.43e-25 | 29 | 113 | 13 | 32527007 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 7.07e-22 | 50 | 113 | 13 | 31806660 |
| Pubmed | 1.98e-12 | 6 | 113 | 5 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 1.98e-12 | 6 | 113 | 5 | 2788608 | |
| Pubmed | 1.98e-12 | 6 | 113 | 5 | 15286789 | ||
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 1.98e-12 | 6 | 113 | 5 | 6608795 | |
| Pubmed | 1.98e-12 | 6 | 113 | 5 | 2081604 | ||
| Pubmed | 6.92e-12 | 7 | 113 | 5 | 8604219 | ||
| Pubmed | 1.84e-11 | 8 | 113 | 5 | 12414807 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 1.84e-11 | 8 | 113 | 5 | 7523515 | |
| Pubmed | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 BCHE USP17L10 USP17L19 USP17L18 CORO2B EGF USP17L17 USP17L3 RPGR USP17L22 USP17L15 | 7.07e-11 | 674 | 113 | 17 | 37196079 | |
| Pubmed | 8.24e-11 | 10 | 113 | 5 | 2897103 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 1.06e-10 | 4 | 113 | 4 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 1.06e-10 | 4 | 113 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 1.06e-10 | 4 | 113 | 4 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 1.06e-10 | 4 | 113 | 4 | 26098870 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 1.06e-10 | 4 | 113 | 4 | 4745489 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 1.06e-10 | 4 | 113 | 4 | 94264 | |
| Pubmed | 1.06e-10 | 4 | 113 | 4 | 3872721 | ||
| Pubmed | 1.06e-10 | 4 | 113 | 4 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 1.06e-10 | 4 | 113 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 1.06e-10 | 4 | 113 | 4 | 6163812 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 1.06e-10 | 4 | 113 | 4 | 2987507 | |
| Pubmed | 1.06e-10 | 4 | 113 | 4 | 6091898 | ||
| Pubmed | 1.06e-10 | 4 | 113 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 1.06e-10 | 4 | 113 | 4 | 6162108 | |
| Pubmed | 1.06e-10 | 4 | 113 | 4 | 16152770 | ||
| Pubmed | 1.06e-10 | 4 | 113 | 4 | 2423416 | ||
| Pubmed | 1.06e-10 | 4 | 113 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 1.06e-10 | 4 | 113 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 1.06e-10 | 4 | 113 | 4 | 2989529 | |
| Pubmed | 1.06e-10 | 4 | 113 | 4 | 6160849 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 1.06e-10 | 4 | 113 | 4 | 1141004 | |
| Pubmed | 1.06e-10 | 4 | 113 | 4 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 1.06e-10 | 4 | 113 | 4 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 1.06e-10 | 4 | 113 | 4 | 6207174 | |
| Pubmed | 1.06e-10 | 4 | 113 | 4 | 2410924 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 1.06e-10 | 4 | 113 | 4 | 2332419 | |
| Pubmed | 1.51e-10 | 11 | 113 | 5 | 7608209 | ||
| Pubmed | 1.51e-10 | 11 | 113 | 5 | 1617215 | ||
| Pubmed | 5.27e-10 | 5 | 113 | 4 | 6529441 | ||
| Pubmed | 5.27e-10 | 5 | 113 | 4 | 6176569 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 5.27e-10 | 5 | 113 | 4 | 34276419 | |
| Pubmed | 5.27e-10 | 5 | 113 | 4 | 1348427 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 5.27e-10 | 5 | 113 | 4 | 8661735 | |
| Pubmed | Purkinje cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice. | 1.58e-09 | 6 | 113 | 4 | 1716634 | |
| Pubmed | 1.58e-09 | 6 | 113 | 4 | 2002257 | ||
| Pubmed | 1.58e-09 | 6 | 113 | 4 | 2450406 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 1.58e-09 | 6 | 113 | 4 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 1.58e-09 | 6 | 113 | 4 | 284003 | |
| Pubmed | Localization of the 70-kDa peroxisomal membrane protein to human 1p21-p22 and mouse 3. | 1.58e-09 | 6 | 113 | 4 | 8449508 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 1.58e-09 | 6 | 113 | 4 | 9250879 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 1.58e-09 | 6 | 113 | 4 | 7859283 | |
| Pubmed | 1.58e-09 | 6 | 113 | 4 | 7946325 | ||
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 1.58e-09 | 6 | 113 | 4 | 1021597 | |
| Pubmed | 1.99e-09 | 17 | 113 | 5 | 25410786 | ||
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 3.67e-09 | 7 | 113 | 4 | 1401878 | |
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 3.67e-09 | 7 | 113 | 4 | 2451911 | |
| Pubmed | 3.67e-09 | 7 | 113 | 4 | 7949740 | ||
| Pubmed | 3.67e-09 | 7 | 113 | 4 | 6160178 | ||
| Pubmed | 3.67e-09 | 7 | 113 | 4 | 8666240 | ||
| Pubmed | 3.67e-09 | 7 | 113 | 4 | 8034329 | ||
| Pubmed | 7.32e-09 | 8 | 113 | 4 | 2040456 | ||
| Pubmed | 7.32e-09 | 8 | 113 | 4 | 3038891 | ||
| Pubmed | 7.32e-09 | 8 | 113 | 4 | 8486361 | ||
| Pubmed | 7.32e-09 | 8 | 113 | 4 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 7.32e-09 | 8 | 113 | 4 | 6200103 | |
| Pubmed | 1.31e-08 | 9 | 113 | 4 | 93520 | ||
| Pubmed | 2.19e-08 | 10 | 113 | 4 | 9121556 | ||
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 32697825 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 3.34e-08 | 3 | 113 | 3 | 2413838 | |
| Pubmed | 3.34e-08 | 3 | 113 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 3.34e-08 | 3 | 113 | 3 | 21827821 | |
| Cytoband | 4p16.1 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 | 1.21e-18 | 79 | 113 | 12 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 | 3.90e-13 | 222 | 113 | 12 | chr4p16 |
| Cytoband | 1p21 | 3.38e-09 | 24 | 113 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 7.19e-06 | 107 | 113 | 5 | chr1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p22 | 1.32e-04 | 104 | 113 | 4 | chr2p22 | |
| Cytoband | 2p22.2 | 6.17e-04 | 15 | 113 | 2 | 2p22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 2.74e-03 | 234 | 113 | 4 | chr8p23 | |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 1.40e-04 | 6 | 56 | 2 | 699 | |
| GeneFamily | WD repeat domain containing | 1.55e-04 | 262 | 56 | 6 | 362 | |
| GeneFamily | Ring finger proteins|Baculoviral IAP repeat containing|Caspase recruitment domain containing | 2.61e-04 | 8 | 56 | 2 | 419 | |
| GeneFamily | Ankyrin repeat domain containing | 9.03e-04 | 242 | 56 | 5 | 403 | |
| GeneFamily | SH2 domain containing | 3.78e-03 | 101 | 56 | 3 | 741 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 HOMER1 USP17L15 | 3.82e-17 | 112 | 110 | 14 | MM1095 |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 4.07e-17 | 86 | 110 | 13 | MM1312 |
| Coexpression | GERY_CEBP_TARGETS | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 HGSNAT USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 6.20e-15 | 160 | 110 | 14 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 HGSNAT USP17L5 USP17L10 USP17L19 USP17L18 PTPN1 USP17L17 USP17L3 USP17L22 USP17L15 | 8.84e-08 | 647 | 110 | 15 | MM981 |
| Coexpression | BERGER_MBD2_TARGETS | 9.47e-08 | 11 | 110 | 4 | MM905 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | CDKN1B GLYAT USP17L21 USP17L12 USP17L1 TBL1Y USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 TBL1XR1 DNAJC2 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 TBCE | 1.02e-07 | 1072 | 110 | 19 | MM1031 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CDKN1B BIN1 MYH9 SYNE1 SPEF2 BIRC2 TBL1XR1 TRIP12 BIRC6 GATAD2B STAT5A STAT5B ANKRD44 PTPN1 GVINP1 MICB EIF4G2 PRKACB ANKRD28 LRBA SORL1 NIN | 2.16e-07 | 1492 | 110 | 22 | M40023 |
| Coexpression | IGLESIAS_E2F_TARGETS_DN | 4.78e-06 | 27 | 110 | 4 | MM643 | |
| Coexpression | GSE25677_MPL_VS_R848_STIM_BCELL_DN | 1.17e-05 | 181 | 110 | 7 | M8187 | |
| Coexpression | LEE_AGING_MUSCLE_UP | 2.64e-05 | 41 | 110 | 4 | MM698 | |
| Coexpression | WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP | 4.20e-05 | 392 | 110 | 9 | M2131 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 8.83e-05 | 432 | 110 | 9 | M41149 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN | 9.81e-05 | 175 | 110 | 6 | M6694 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | EPRS1 TAF1B BIRC2 SLU7 DMXL1 TDRD7 CEBPZ RAD54B RPGR SORL1 NIN | 1.01e-04 | 656 | 110 | 11 | M18979 |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 1.19e-04 | 60 | 110 | 4 | MM654 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_UP | 1.32e-04 | 116 | 110 | 5 | MM1240 | |
| Coexpression | BRUINS_UVC_RESPONSE_LATE | GLYAT USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 TSC2 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 1.46e-04 | 1198 | 110 | 15 | MM1062 |
| Coexpression | GSE15659_TREG_VS_TCONV_UP | 1.67e-04 | 193 | 110 | 6 | M3534 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | EPRS1 BIN1 AMY1A AMY1B AMY1C AMY2A AMY2B ZNF337 TAF1B HGSNAT DMXL1 ZNHIT6 MICB PRKACB LRBA | 1.70e-04 | 1215 | 110 | 15 | M41122 |
| Coexpression | YAGI_AML_WITH_T_8_21_TRANSLOCATION | 1.78e-04 | 372 | 110 | 8 | M19261 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 HGSNAT USP17L5 USP17L10 USP17L19 USP17L18 PTPN1 USP17L17 USP17L3 USP17L22 USP17L15 | 1.87e-04 | 1226 | 110 | 15 | MM979 |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | 1.98e-04 | 481 | 110 | 9 | M3898 | |
| Coexpression | BENPORATH_ES_1 | 2.02e-04 | 379 | 110 | 8 | M1871 | |
| Coexpression | GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_DN | 2.03e-04 | 200 | 110 | 6 | M9374 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP | 2.03e-04 | 200 | 110 | 6 | M6618 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 2.03e-04 | 200 | 110 | 6 | M4449 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 2.41e-04 | 132 | 110 | 5 | MM470 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | CDKN1B SPEF2 PRAG1 STAT5B ANKRD44 GVINP1 PIK3CG ANKRD28 IFT80 | 2.55e-04 | 498 | 110 | 9 | M1741 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | MYH9 SPOCK1 SLU7 TBL1XR1 BIRC6 GATAD2B DNAJC2 STAT5A STAT5B ANKRD44 CORO2B ROBO1 IFT80 SORL1 | 1.54e-05 | 806 | 96 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-06 | 156 | 105 | 6 | 4d2679e7639758c49fc25a2deb9109b08f0a3e57 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.33e-06 | 192 | 105 | 6 | 46ea8f4f292db70420b378c6fa3e55e99413679c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.92e-06 | 195 | 105 | 6 | 60d08fb27469d1e247bc47b651d7023ba82cf92f | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.76e-05 | 159 | 105 | 5 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-05 | 162 | 105 | 5 | 36ddebe3bb172c992739353b7b049b2dde98b559 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.48e-05 | 165 | 105 | 5 | 7d319a112b9062efee428bef6f4534d2ce782e04 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.75e-05 | 167 | 105 | 5 | ded4d6cccd3660662f12cf5a512de31d26325f1b | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.17e-05 | 170 | 105 | 5 | df1a34a69ae404c56f00751a01f52359535f5469 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-05 | 173 | 105 | 5 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-05 | 173 | 105 | 5 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 175 | 105 | 5 | 91cb819a1786020713b7e64480de0545380daae9 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-05 | 177 | 105 | 5 | d445167dae956e641386f84ab3ae9f47c089e09a | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 178 | 105 | 5 | 0b456ac768e026c3ecd5a9a4f43d6f126e7685a1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.95e-05 | 181 | 105 | 5 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.51e-05 | 184 | 105 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-05 | 184 | 105 | 5 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 7.71e-05 | 185 | 105 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 7.91e-05 | 186 | 105 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.32e-05 | 188 | 105 | 5 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.32e-05 | 188 | 105 | 5 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.53e-05 | 189 | 105 | 5 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.53e-05 | 189 | 105 | 5 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 8.74e-05 | 190 | 105 | 5 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.74e-05 | 190 | 105 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.96e-05 | 191 | 105 | 5 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 9.41e-05 | 193 | 105 | 5 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.41e-05 | 193 | 105 | 5 | dd9874898587fe9fd9cf2aebc2e0579dcf06944e | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 9.64e-05 | 194 | 105 | 5 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.64e-05 | 194 | 105 | 5 | f08a7618a9ccf12e4a7620235ae662a8abc521af | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 195 | 105 | 5 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 9.87e-05 | 195 | 105 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | Control-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 9.87e-05 | 195 | 105 | 5 | 6687e579582d7a239bee80846de0cf827a6f6a62 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 1.01e-04 | 196 | 105 | 5 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-04 | 197 | 105 | 5 | adc7bf2120fad4aea58123d882a8cf18ed4174d0 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.04e-04 | 197 | 105 | 5 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.04e-04 | 197 | 105 | 5 | ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-04 | 197 | 105 | 5 | e133bd09efc6d7f539fc1a1ac7a945f07103d6e6 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.11e-04 | 200 | 105 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Drug | R 623 | 8.39e-12 | 6 | 99 | 5 | CID003027594 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 8.39e-12 | 6 | 99 | 5 | CID003083414 | |
| Drug | dimethylaminomethylferrocene | 8.39e-12 | 6 | 99 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 8.39e-12 | 6 | 99 | 5 | CID000127364 | |
| Drug | CNP-G3 | 8.39e-12 | 6 | 99 | 5 | CID003082910 | |
| Drug | AC1L5BOU | 2.93e-11 | 7 | 99 | 5 | CID000174858 | |
| Drug | BG5P | 2.93e-11 | 7 | 99 | 5 | CID003082752 | |
| Drug | desethylaprophen | 7.78e-11 | 8 | 99 | 5 | CID000163919 | |
| Drug | azintamide | 7.78e-11 | 8 | 99 | 5 | CID000071105 | |
| Drug | aprophen | 1.03e-10 | 18 | 99 | 6 | CID000071128 | |
| Drug | alpha-maltosyl fluoride | 1.74e-10 | 9 | 99 | 5 | CID000194237 | |
| Drug | trestatin A | 1.74e-10 | 9 | 99 | 5 | CID003054994 | |
| Drug | N-PMT | 3.36e-10 | 4 | 99 | 4 | CID000194224 | |
| Drug | AC1MQT4V | 3.36e-10 | 4 | 99 | 4 | CID003482066 | |
| Drug | SAIB-SG | 3.36e-10 | 4 | 99 | 4 | CID002735139 | |
| Drug | 2-nitropropyl acetate | 3.36e-10 | 4 | 99 | 4 | CID013573844 | |
| Drug | Dembrexine | 3.36e-10 | 4 | 99 | 4 | CID000072009 | |
| Drug | g lw | 3.36e-10 | 4 | 99 | 4 | CID000444139 | |
| Drug | beta-santalene | 3.36e-10 | 4 | 99 | 4 | CID000010534 | |
| Drug | AC1LAC07 | 3.48e-10 | 10 | 99 | 5 | CID000485275 | |
| Drug | CG-120 | 3.48e-10 | 10 | 99 | 5 | CID000171403 | |
| Drug | Glc)4 | 3.48e-10 | 10 | 99 | 5 | CID000189098 | |
| Drug | Ro 20-0083 | 3.48e-10 | 10 | 99 | 5 | CID003082332 | |
| Drug | AC1L3M0Q | 3.48e-10 | 10 | 99 | 5 | CID000118008 | |
| Drug | validamycin D | 6.35e-10 | 11 | 99 | 5 | CID000166726 | |
| Drug | FG5P | 6.35e-10 | 11 | 99 | 5 | CID000127486 | |
| Drug | CNP-G5 | 6.35e-10 | 11 | 99 | 5 | CID000127309 | |
| Drug | HgI2 | 6.35e-10 | 11 | 99 | 5 | CID000024485 | |
| Drug | 2C KM | 6.35e-10 | 11 | 99 | 5 | CID009549196 | |
| Drug | azaprophen | 1.09e-09 | 12 | 99 | 5 | CID000129486 | |
| Drug | Deposiston | 1.68e-09 | 5 | 99 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 1.68e-09 | 5 | 99 | 4 | CID010358258 | |
| Drug | lunularic acid | 1.68e-09 | 5 | 99 | 4 | CID000161413 | |
| Drug | himachalene | 1.68e-09 | 5 | 99 | 4 | CID000015095 | |
| Drug | actinidine | 1.68e-09 | 5 | 99 | 4 | CID000068231 | |
| Drug | 2TAA | 1.68e-09 | 5 | 99 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 1.68e-09 | 5 | 99 | 4 | CID006449879 | |
| Drug | silver perchlorate | 1.68e-09 | 5 | 99 | 4 | CID000024562 | |
| Drug | AC1L4DZ4 | 1.68e-09 | 5 | 99 | 4 | CID000155287 | |
| Drug | methyl 1'-epiacarviosin | 1.76e-09 | 13 | 99 | 5 | CID000197426 | |
| Drug | isoacarbose | 1.76e-09 | 13 | 99 | 5 | CID000449165 | |
| Drug | Cyclodextrins | 2.72e-09 | 14 | 99 | 5 | CID000024238 | |
| Drug | 2-chloro-4-nitrophenol | 2.72e-09 | 14 | 99 | 5 | CID000012074 | |
| Drug | terephthaloyl chloride | 2.72e-09 | 14 | 99 | 5 | CID000007488 | |
| Drug | 4-nitrophenylmaltoheptaoside | 4.07e-09 | 15 | 99 | 5 | CID000173254 | |
| Drug | 2-amino-6-picoline | 5.01e-09 | 6 | 99 | 4 | CID000015765 | |
| Drug | phenol blue | 5.01e-09 | 6 | 99 | 4 | CID000075078 | |
| Drug | Gu-4 | 5.01e-09 | 6 | 99 | 4 | CID000448679 | |
| Drug | Borane dimethylamine complex | 5.01e-09 | 6 | 99 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 5.01e-09 | 6 | 99 | 4 | CID000092801 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 5.01e-09 | 6 | 99 | 4 | CID009577343 | |
| Drug | AC1OAGH8 | 5.01e-09 | 6 | 99 | 4 | CID006857368 | |
| Drug | vermella | 5.01e-09 | 6 | 99 | 4 | CID000203726 | |
| Drug | hymenin | 5.01e-09 | 6 | 99 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 5.01e-09 | 6 | 99 | 4 | CID000011615 | |
| Drug | gamma-cyclodextrin | 5.90e-09 | 16 | 99 | 5 | CID000086575 | |
| Drug | Bay e 4609 | 5.90e-09 | 16 | 99 | 5 | CID003085308 | |
| Drug | trimitan | 1.15e-08 | 18 | 99 | 5 | CID000005561 | |
| Drug | methyl blue | 1.17e-08 | 7 | 99 | 4 | CID011969534 | |
| Drug | 3KBG5CNP | 1.17e-08 | 7 | 99 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 1.17e-08 | 7 | 99 | 4 | CID000071762 | |
| Drug | Paramax | 1.17e-08 | 7 | 99 | 4 | CID000156411 | |
| Drug | amino-methyl | 1.17e-08 | 7 | 99 | 4 | CID000142005 | |
| Drug | boric acid gel | 2.32e-08 | 8 | 99 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 2.32e-08 | 8 | 99 | 4 | CID005317411 | |
| Drug | N-vinylcaprolactam | 2.32e-08 | 8 | 99 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 2.32e-08 | 8 | 99 | 4 | CID000146692 | |
| Drug | acrinor | 2.32e-08 | 8 | 99 | 4 | CID005489637 | |
| Drug | NSC300622 | 2.32e-08 | 8 | 99 | 4 | CID000028426 | |
| Drug | theodrenaline | 2.32e-08 | 8 | 99 | 4 | CID000071857 | |
| Drug | rhodanile blue | 2.32e-08 | 8 | 99 | 4 | CID000073372 | |
| Drug | AC1L3XPY | 2.70e-08 | 21 | 99 | 5 | CID000124005 | |
| Drug | maltosaccharide | 3.49e-08 | 22 | 99 | 5 | CID005461034 | |
| Drug | GSAD | 4.17e-08 | 9 | 99 | 4 | CID009909127 | |
| Drug | GU-3 | 4.17e-08 | 9 | 99 | 4 | CID000448687 | |
| Drug | zingiberene | 4.17e-08 | 9 | 99 | 4 | CID000092776 | |
| Drug | Atonik | 4.17e-08 | 9 | 99 | 4 | CID000069471 | |
| Drug | H 187 | 4.17e-08 | 9 | 99 | 4 | CID000001742 | |
| Drug | mercuric nitrate | 4.17e-08 | 9 | 99 | 4 | CID000024864 | |
| Drug | taselin | 4.44e-08 | 23 | 99 | 5 | CID000023846 | |
| Drug | NSC626779 | 4.72e-08 | 46 | 99 | 6 | CID000116733 | |
| Drug | kasugamycin | 5.39e-08 | 47 | 99 | 6 | CID000065174 | |
| Drug | Panose B | 5.59e-08 | 24 | 99 | 5 | CID000439297 | |
| Drug | I ZE | 6.92e-08 | 10 | 99 | 4 | CID009549200 | |
| Drug | trans-cinnamamide | 6.92e-08 | 10 | 99 | 4 | CID000012135 | |
| Drug | eicosa-11,14-dienoic acid | 6.92e-08 | 10 | 99 | 4 | CID000003208 | |
| Drug | UDP-pyridoxal | 6.92e-08 | 10 | 99 | 4 | CID000126789 | |
| Drug | naphthalene-1,3,6,8-tetrol | 6.92e-08 | 10 | 99 | 4 | CID000440202 | |
| Drug | CID439354 | 6.96e-08 | 25 | 99 | 5 | CID000439354 | |
| Drug | AC1N3UXZ | 7.97e-08 | 3 | 99 | 3 | CID004118625 | |
| Drug | Tempamine | 1.08e-07 | 11 | 99 | 4 | CID000550942 | |
| Drug | L-tert-leucine | 1.08e-07 | 11 | 99 | 4 | CID000164608 | |
| Drug | AMO-1618 | 1.08e-07 | 11 | 99 | 4 | CID000017103 | |
| Drug | AC1L8PXO | 1.08e-07 | 11 | 99 | 4 | CID000430710 | |
| Drug | pentylamine | 1.13e-07 | 53 | 99 | 6 | CID000008060 | |
| Drug | pp J | 1.53e-07 | 29 | 99 | 5 | CID006323476 | |
| Drug | chloroisocyanuric acid | 1.62e-07 | 12 | 99 | 4 | CID000017921 | |
| Drug | glyciphosphoramide | 1.62e-07 | 12 | 99 | 4 | CID000197092 | |
| Drug | chitosan | 1.62e-07 | 12 | 99 | 4 | CID000071853 | |
| Drug | Avenin | 1.62e-07 | 12 | 99 | 4 | CID000095924 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 8.05e-24 | 46 | 109 | 14 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L21 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L15 | 4.84e-21 | 69 | 109 | 14 | DOID:1682 (implicated_via_orthology) |
| Disease | alpha-amylase 1 measurement | 2.19e-08 | 9 | 109 | 4 | EFO_0801371 | |
| Disease | Autistic Disorder | 5.92e-06 | 261 | 109 | 8 | C0004352 | |
| Disease | pituitary adenoma (implicated_via_orthology) | 1.35e-05 | 2 | 109 | 2 | DOID:3829 (implicated_via_orthology) | |
| Disease | sensory system disease (implicated_via_orthology) | 4.05e-05 | 3 | 109 | 2 | DOID:0050155 (implicated_via_orthology) | |
| Disease | pheochromocytoma (implicated_via_orthology) | 8.07e-05 | 4 | 109 | 2 | DOID:0050771 (implicated_via_orthology) | |
| Disease | paraganglioma (implicated_via_orthology) | 1.34e-04 | 5 | 109 | 2 | DOID:0050773 (implicated_via_orthology) | |
| Disease | Carcinoma, Lobular | 2.01e-04 | 6 | 109 | 2 | C0206692 | |
| Disease | Opitz GBBB syndrome (implicated_via_orthology) | 2.01e-04 | 6 | 109 | 2 | DOID:0080697 (implicated_via_orthology) | |
| Disease | Mental deterioration | 4.79e-04 | 9 | 109 | 2 | C0234985 | |
| Disease | Mild cognitive disorder | 4.79e-04 | 9 | 109 | 2 | C1270972 | |
| Disease | Adult Hepatocellular Carcinoma | 4.79e-04 | 9 | 109 | 2 | C0279607 | |
| Disease | Facies | 5.97e-04 | 10 | 109 | 2 | C0282631 | |
| Disease | Carcinoma, Neuroendocrine | 8.71e-04 | 12 | 109 | 2 | C0206695 | |
| Disease | Obesity | 1.00e-03 | 205 | 109 | 5 | C0028754 | |
| Disease | Impaired cognition | 1.20e-03 | 14 | 109 | 2 | C0338656 | |
| Disease | T-Cell Lymphoma | 1.57e-03 | 16 | 109 | 2 | C0079772 | |
| Disease | Multiple congenital anomalies | 1.77e-03 | 17 | 109 | 2 | C0000772 | |
| Disease | non-word reading | 1.98e-03 | 67 | 109 | 3 | EFO_0005299 | |
| Disease | urate measurement, bone density | 2.13e-03 | 619 | 109 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | Retinal Degeneration | 2.71e-03 | 21 | 109 | 2 | C0035304 | |
| Disease | Mammary Carcinoma, Human | 3.40e-03 | 525 | 109 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 3.40e-03 | 525 | 109 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 3.47e-03 | 527 | 109 | 7 | C1458155 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 3.62e-03 | 169 | 109 | 4 | DOID:3908 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKRWANFAKYGNPNE | 496 | P06276 | |
| HGANPLLKNKDGWNS | 126 | Q6P6B7 | |
| AAKKPLNGNQWSFIN | 2191 | Q9NR09 | |
| CLGFKWELHQPQLFQ | 86 | Q32M84 | |
| QAVAPSEGANKHKGW | 1021 | Q12774 | |
| KKQPHEPHDNENNKW | 836 | Q7Z2Y8 | |
| GRIEEPFWQNFKHLQ | 306 | Q9BYG8 | |
| HNAPVKVKNAQGWSP | 166 | Q8N6S4 | |
| LDKLHNLNSNWFPEG | 226 | P0DTE7 | |
| LDKLHNLNSNWFPEG | 226 | P0DTE8 | |
| NWQTPLHIAAANKAV | 106 | O15084 | |
| LDKLHNLNSNWFPEG | 226 | P0DUB6 | |
| LDKLHNLNSNWFPAG | 226 | P19961 | |
| SQRKWNFDFQNHKPL | 56 | P46527 | |
| QPHPGWQGTLKAKNF | 66 | P19835 | |
| PKDWKNQDHYAVLGL | 81 | Q99543 | |
| KTGPFVVHWLNNKEL | 386 | Q9Y485 | |
| IIFHPWKKEENGNQS | 411 | Q3KR37 | |
| SQLGHSQPFKQEWLN | 1866 | Q9C0F0 | |
| NFPDPAGKLNQFWKN | 121 | Q6GMV1 | |
| NWLNKVNPHKVSPAS | 476 | Q9UHB7 | |
| PRPDKNHQWVFNKNC | 266 | Q9Y620 | |
| GNRDTPLHWAAFKNN | 116 | Q9H765 | |
| LDKLHNLNSNWFPAG | 226 | P04746 | |
| VKINGKHYNWAVAAP | 481 | Q9BQK8 | |
| NGKCREFFPNHQWVK | 321 | P18031 | |
| QDLQGHLQKVKPQWF | 81 | Q7Z418 | |
| LVVFNWKLHQGKANE | 311 | A6NM62 | |
| NHGNPFNLKAVVDKW | 36 | Q6IB77 | |
| HNLCKPAWKGSQQFS | 1446 | Q5H9U9 | |
| KSQEQIPNHWFTKGN | 1026 | Q5CZC0 | |
| KNNLLLKWDFDNRPH | 591 | P05160 | |
| ANRLFAVNKWHNLPA | 2541 | P50851 | |
| WKKENGFPAGVDNPH | 496 | A0A1B0GTW7 | |
| NKKNSGQHLPIFPAW | 166 | Q9BSJ2 | |
| FINNPLAQADWAAKK | 16 | P35579 | |
| AKPQGQWAENVLGAK | 66 | Q29980 | |
| NWQTPLHVAAANKAV | 106 | Q8N8A2 | |
| DFTPHWKQEKNGKIL | 426 | Q8WXI9 | |
| KGSSNKPLNDNQWHN | 976 | Q9ULB1 | |
| EFPGKGKALFQVNQW | 876 | P78344 | |
| AHVFQIDPNTKKNWV | 11 | Q86YM7 | |
| ESKQNPGNHWQKADI | 1626 | Q5VYJ5 | |
| WANQCHSKFDKDGQP | 591 | Q9HDB9 | |
| QPNAKVLQWKAHDGI | 176 | Q9P2H3 | |
| DFLKKWENPTQNNAG | 26 | P22694 | |
| PQIIQKKANGNCFWH | 536 | Q96PB1 | |
| HQGNVLDIKWNPFID | 86 | Q9UQ03 | |
| PWFVVIKEHQDLKNG | 1096 | P01133 | |
| QGKAKNPWPNVDAHS | 391 | O75390 | |
| KQQFCWHVKLQFPQS | 341 | Q9NWK9 | |
| FPFQWKLKDNQSHKE | 621 | Q68CP4 | |
| LKHGQLKWFRDNAVP | 411 | Q8IX15 | |
| AAPQWCQGKLQAHLV | 181 | O00499 | |
| WVHFDNLKGGKQLNK | 681 | Q03701 | |
| NPGKFWFKNDVPVHL | 26 | Q92834 | |
| LKRPDHKQDFVAQWQ | 1071 | Q9C093 | |
| HPNKQLWKSDDFGQT | 226 | Q92673 | |
| AINWNKHLDGDNVKF | 186 | Q6IMI4 | |
| NNALINWHHPEKDKA | 431 | Q9NQ86 | |
| ECFKLFHPWGTQKAQ | 196 | Q7Z4K8 | |
| WGNLNITKIHKNADG | 571 | P07814 | |
| PAGSDLAQKWHLIKQ | 221 | O75159 | |
| NAKKDFFRNLPHWIQ | 641 | Q8NF91 | |
| EPHGFNFWGKLEKNI | 216 | P48775 | |
| QGQQKKPFEEHWRKH | 611 | P31040 | |
| LHKQLQNAGGKSWAP | 1806 | Q8N4C6 | |
| VGPELKNDVLHNFWK | 96 | Q53T94 | |
| AQKSKAPWLNLHGQQ | 716 | Q5UE93 | |
| EGTQSPLHWNFKKNI | 1286 | Q5VXU9 | |
| FKKNIWEQENHPFNL | 1296 | Q5VXU9 | |
| KPHWNDGAILGFVNK | 586 | P51692 | |
| LPVHNKFSNWCGVQK | 4136 | Q9P2P6 | |
| NKHNNGIWISKLPHF | 246 | Q8NHU6 | |
| TLGQHKGPIFALKWN | 261 | Q9BZK7 | |
| SHWGLPVQKLEKVNQ | 231 | Q5VYV7 | |
| KAKEHIQAIGKPWQA | 331 | Q9Y2V3 | |
| KPHWNDGAILGFVNK | 586 | P42229 | |
| DNWKLGDSPIQKHKQ | 91 | Q13490 | |
| HKKTQQLLNPVDWNF | 251 | Q9UBY8 | |
| FPNAKKEHVPTWLQN | 521 | O43734 | |
| IQHIWGKNGKEVSNF | 266 | Q86WS4 | |
| PIKNFQWVRHCLKNG | 286 | P48736 | |
| LPAGSKKNWNHVVDA | 66 | Q9NP50 | |
| KKNWNHVVDARAGPS | 71 | Q9NP50 | |
| HWKFLQEQNKTKPEF | 436 | A6NCW0 | |
| HPAQKNFCKNGIWEN | 246 | Q8NHY6 | |
| CSHFAQDLWPKQGLK | 111 | Q14593 | |
| TKIQWHGKDNQVPKS | 481 | Q7RTX1 | |
| NEWKQAGGHKDPEKN | 391 | Q15813 | |
| WGHKPFNKELFLQAN | 171 | Q8N5U6 | |
| HWKFLQEQNKTKPEF | 436 | D6R9N7 | |
| HWKFLQEQNKTKPEF | 436 | A8MUK1 | |
| NVAQKHWVGPSNLVK | 121 | Q08629 | |
| HWKFLQEQNKTKPEF | 436 | D6R901 | |
| KHFGWKADLRNPQLE | 236 | Q9BTF0 | |
| NILVVGFKKNWQSAH | 736 | P55017 | |
| SGKLVEQANSPKHQW | 206 | O95391 | |
| HWKFLQEQNKTKPEF | 436 | D6RCP7 | |
| QHLDNVDQTGPKAWK | 146 | O43159 | |
| EKHWKPLGQQKQEVA | 1096 | Q9Y6N7 | |
| HWKFLQEQNKTKPEF | 436 | Q7RTZ2 | |
| TLGQHKGPIFALKWN | 271 | Q9BQ87 | |
| GGQKKELHFNENNWS | 976 | Q86YV5 | |
| HWKFLQEQNKTKPEF | 436 | C9JPN9 | |
| HWKFLQEQNKTKPEF | 436 | Q0WX57 | |
| QKNRHFEKQDVLVPW | 146 | Q9P272 | |
| GNLKHKCFRWPQENE | 261 | Q01118 | |
| AAAAAQPEHKQQKLW | 46 | Q14CZ0 | |
| HWKFLQEQNKTKPEF | 436 | D6RA61 | |
| QRHPDCANVKQWKGG | 1271 | Q14669 | |
| HWKFLQEQNKTKPEF | 436 | C9J2P7 | |
| HWKFLQEQNKTKPEF | 436 | D6RBQ6 | |
| HWKFLQEQNKTKPEF | 436 | D6RJB6 | |
| AQSIHPAKDGWIQNL | 431 | P49815 | |
| HWKFLQEQNKTKPEF | 436 | C9JJH3 | |
| GQGFIWKSNLVKHQL | 606 | Q9Y3M9 | |
| HWKFLQEQNKTKPEF | 436 | C9JVI0 | |
| HGFWRKKIQPQEASE | 56 | Q8N402 | |
| QQPLHPEWAALAKKQ | 36 | P22033 |